Lisa Gill

Q: What is Lisa Gill's success rate?

Lisa Gill currently has a success rate of 84.26662618598169.

Q: What is the average return of Lisa Gill's calls?

Their stock ratings have generated an average return of 10.915899744637214.

JP Morgan | Healthcare

Lisa Gill is an analyst from JP Morgan specializing in the Healthcare sector. Ranked #1821 out of 4639 analysts, they have issued 31 stock ratings with a success rate of 84.27% and an average return of 10.92%.

Lisa Gill has a well-established track record, with 31 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 84.27% and an average return of 10.92%, underscoring their expertise and ability to identify winning opportunities for investors.

#1821

Out of 4639

Total Ratings

+84.27%

Success Rate

+10.92%

Average Return

Recent Ratings Analysis

AGL

Sell

May 04, 2026

Target

$21.00

Current

$26.94

Performance

0.00%

Lisa Gill rated AGL as Underweight on May 04, 2026, setting a price target of 21. So far, the bearish outlook hasn’t materialized, with shares flat near 26.94.

OPCH

Buy

May 04, 2026

Target

$33.00

Current

$21.14

Performance

0.00%

On May 04, 2026, OPCH was given a Overweight rating by Lisa Gill, with a target price of 33. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

CAH

Hold

May 04, 2026

Target

$215.00

Current

$197.06

Performance

0.00%

CAH received a Neutral rating from Lisa Gill on May 04, 2026, aiming for 215. Shares remained flat at 197.06, aligning with the neutral rating.

HUM

Hold

May 01, 2026

Target

$214.00

Current

$237.96

Performance

—

On May 01, 2026, Lisa Gill published a Neutral outlook on HUM, with a target of 214. Sideways action left the Hold view intact, with no major move since 237.96.

ELV

Buy

Apr 28, 2026

Target

$411.00

Current

$371.90

Performance

2.53%

Lisa Gill on Apr 28, 2026 assigned ELV a Overweight rating, with a price target of 411. The recommendation remains pending validation as shares consolidate around 371.9.

UNH

Buy

Apr 28, 2026

Target

$420.00

Current

$370.75

Performance

1.09%

On Apr 28, 2026, Lisa Gill reaffirmed UNH with a Overweight rating, targeting 420. Market indecision has kept the 420 target in a holding pattern.

TDOC

Hold

Mar 13, 2026

Target

$7.00

Current

$6.63

Performance

23.46%

TDOC was rated Neutral by Lisa Gill on Mar 13, 2026, with a price objective of 7. Despite caution, upside momentum rewarded risk-takers with gains to 6.63.

MDLN

Buy

Mar 10, 2026

Target

$53.00

Current

$44.19

Performance

3.06%

On Mar 10, 2026, Lisa Gill initiated coverage on MDLN with a Overweight rating and target of 53. Neutral price movement of 3.06% leaves room for interpretation.

GDRX

Hold

Feb 27, 2026

Target

—

Current

$2.50

Performance

33.69%

Lisa Gill issued a Neutral recommendation for GDRX on Feb 27, 2026, price target set at null. A neutral call gave way to stronger-than-expected performance, closing in on null.

LH

Buy

Feb 18, 2026

Target

$330.00

Current

$253.01

Performance

-9.24%

On Feb 18, 2026, LH was evaluated by Lisa Gill, who gave a Overweight rating and target of 330. Investors saw limited payoff as shares fell short of the 330 target.

COR

Buy

Feb 10, 2026

Target

$419.00

Current

$303.66

Performance

-15.65%

Lisa Gill rated COR as Overweight on Feb 10, 2026, setting a price target of 419. The stock has underperformed, dropping 15.65% despite the bullish target of 419.

MCK

Buy

Feb 10, 2026

Target

$1.11

Current

$807.85

Performance

-13.62%

On Feb 10, 2026, MCK was given a Overweight rating by Lisa Gill, with a target price of 1.11. Despite the Buy call, shares fell from 807.85 to 807.85, challenging the optimistic stance.

CVS

Buy

Dec 17, 2025

Target

$101.00

Current

$82.01

Performance

5.30%

CVS received a Overweight rating from Lisa Gill on Dec 17, 2025, aiming for 101. Momentum has favored the Buy call, with shares climbing from 82.01 to 82.01, rewarding those who trusted the recommendation.

ALHC

Buy

Dec 17, 2025

Target

$23.00

Current

$19.26

Performance

-6.28%

On Dec 17, 2025, Lisa Gill published a Overweight outlook on ALHC, with a target of 23. Market action contradicted the Buy thesis, as shares slipped to 19.26.

PRVA

Buy

Nov 13, 2025

Target

$33.00

Current

$24.24

Performance

2.06%

Lisa Gill on Nov 13, 2025 assigned PRVA a Overweight rating, with a price target of 33. The recommendation remains pending validation as shares consolidate around 24.24.

PGNY

Hold

Nov 11, 2025

Target

$26.00

Current

$18.91

Performance

-20.58%

On Nov 11, 2025, Lisa Gill reaffirmed PGNY with a Neutral rating, targeting 26. The Hold stance reflected market caution that was later justified.

CI

Buy

Nov 04, 2025

Target

$375.00

Current

$279.35

Performance

5.55%

CI was rated Overweight by Lisa Gill on Nov 04, 2025, with a price objective of 375. A bullish response from the market helped close the gap of 95.65 to the target.

AVAH

Hold

Sep 18, 2025

Target

$10.00

Current

$6.63

Performance

-21.63%

On Sep 18, 2025, Lisa Gill initiated coverage on AVAH with a Neutral rating and target of 10. The rating matched the stock’s inability to hold above 6.63.

OMI

Sell

Aug 27, 2025

Target

$6.00

Current

$2.68

Performance

-45.19%

Lisa Gill issued a Underweight recommendation for OMI on Aug 27, 2025, price target set at 6. The Sell call exposed risks of betting against momentum, as the stock rallied -45.19%.

CON

Buy

Mar 19, 2025

Target

$30.00

Current

$22.67

Performance

7.85%

On Mar 19, 2025, CON was evaluated by Lisa Gill, who gave a Overweight rating and target of 30. This case illustrates how a timely bullish rating can translate into tangible gains of 7.85%.

DGX

Hold

Feb 04, 2025

Target

$180.00

Current

$191.50

Performance

17.23%

Lisa Gill rated DGX as Neutral on Feb 04, 2025, setting a price target of 180. Despite the Hold call, shares climbed 17.23% to 191.5, revealing unexpected momentum.

INNV

Sell

Dec 17, 2024

Target

$5.00

Current

$8.17

Performance

100.25%

On Dec 17, 2024, INNV was given a Underweight rating by Lisa Gill, with a target price of 5. The Sell stance aligned with downward action, with the stock sliding from 8.17 to 8.17.

PACS

Hold

Dec 17, 2024

Target

$18.00

Current

$32.52

Performance

133.12%

PACS received a Neutral rating from Lisa Gill on Dec 17, 2024, aiming for 18. Investors saw gains of 133.12% that the cautious stance didn’t fully capture.

SGRY

Hold

Dec 03, 2024

Target

$28.00

Current

$14.20

Performance

-38.26%

On Dec 03, 2024, Lisa Gill published a Neutral outlook on SGRY, with a target of 28. Weakness in the stock, now at 14.2, supported the conservative rating.

MOH

Buy

Jul 10, 2024

Target

$395.00

Current

$195.53

Performance

-31.86%

Lisa Gill on Jul 10, 2024 assigned MOH a Overweight rating, with a price target of 395. The call has struggled to gain traction, with shares losing 31.86%.

WBA

Buy

Jul 01, 2024

Target

$20.00

Current

$11.98

Performance

3.45%

On Jul 01, 2024, Lisa Gill reaffirmed WBA with a Overweight rating, targeting 20. Market indecision has kept the 20 target in a holding pattern.

Frequency Asked Questions

Who is Lisa Gill?

Lisa Gill is an analyst from JP Morgan specializing in the Healthcare sector.

What is Lisa Gill's success rate?

Lisa Gill currently has a success rate of +84.27%.

How many ratings has Lisa Gill issued?

Lisa Gill has issued 31 stock ratings so far.

What is the average return of Lisa Gill's calls?

Their stock ratings have generated an average return of +10.92%.

What is Lisa Gill's ranking?

Lisa Gill is ranked #1821 out of 4639 analysts.

What types of ratings does Lisa Gill give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Lisa Gill?

You can follow Lisa Gill by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Lisa Gill?

Their latest rating was a Sell on AGL issued on 2026-05-04.